I-Corps: Translation Potential of an Elastomeric Low-Friction Fluoropolymer Alternative for the Medical Device Industry

I-Corps：医疗器械行业弹性体低摩擦含氟聚合物替代品的转化潜力

• 批准号: 2406968
• 负责人: Travis Bailey
• 金额: $ 5万
• 依托单位: Colorado State University
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 2024
• 资助国家: 美国
• 起止时间: 2024-03-01 至 2025-02-28
• 项目状态: 未结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=2406968&HistoricalAwards=false
• 关键词: Corps; Translation; Potential; Elastomeric; Low

The broader impact of this I-Corps project is the development of a new medical polymer possessing a unique and rare combination of elastic-like durability and gel-like lubrication properties. These new hydrogel elastomers have the potential for broad impact across the U.S. healthcare and medical device industries. Their utility as both a low-friction, durable structural design material and as a bio-inert surface coating alternative makes them relevant in a wide range of new and existing medical device technologies. To avoid environmentally damaging perfluoroalkyl substances (PFAS) substances, the need for new, low friction, durable polymer alternatives has become more acute. This technology is in a prime position to fill an emerging void in the biomedical materials landscape. The potential broader impact can be extended to new tools, ranging from complex surgical instruments and implant technologies to simple wound care dressings and medical tubing.This I-Corps project utilizes experiential learning coupled with a first-hand investigation of the industry ecosystem to assess the translation potential of the technology. The solution is based on the development of thermoplastic elastomer (TPE) hydrogels possessing the necessary durability, elasticity, wear resistance, biostability, and biocompatibility to be considered as structural materials in medical device design. These materials were engineered to exhibit intrinsic surface lubricity at a range of material durometers while remaining perfluoroalkyl substance- (PFAS) and fluoropolymer-free. TPEs are key components in a broad range of medical devices, but there is a critical need for low friction lubricity at the exposed surface to minimize interactions with biological tissues. Existing TPE materials lack such lubricity, and biomedical device designers are forced to depend on expensive and complex hydrophilic surface treatments or on the use of hydrophobic, fluoropolymer liners or resin coatings to achieve low surface friction and biological surface passivation. Hydrogel based materials, with their intrinsic lubricity and tendency to suppress bioactivation, have been touted as possible players in such devices, and the hydrogel material technology this project explores would be one of the first on the market that can meet the durability demands required in most product applications.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.

I-Corps项目的更广泛影响是开发一种新的医用聚合物，该聚合物具有独特而罕见的弹性耐久性和凝胶润滑性能。这些新型水凝胶弹性体有可能对美国医疗保健和医疗器械行业产生广泛影响。它们作为低摩擦、耐用的结构设计材料和生物惰性表面涂层替代品的实用性使它们与各种新的和现有的医疗器械技术相关。为了避免全氟烷基物质（PFAS）对环境造成破坏，对新的、低摩擦、耐用的聚合物替代品的需求变得更加迫切。这项技术在填补生物医学材料领域的一个新兴空白方面处于领先地位。潜在的更广泛的影响可以扩展到新的工具，从复杂的外科器械和植入技术到简单的伤口护理敷料和医用管道。这个I-Corps项目利用体验式学习加上对行业生态系统的第一手调查来评估技术的转化潜力。该解决方案基于热塑性弹性体（TPE）水凝胶的开发，该水凝胶具有必要的耐久性、弹性、耐磨性、生物稳定性和生物相容性，可作为医疗器械设计中的结构材料。这些材料被设计为在一系列材料硬度下表现出固有的表面润滑性，同时保持不含全氟烷基物质（PFAS）和含氟聚合物。TPE是各种医疗器械中的关键组件，但在暴露表面处迫切需要低摩擦润滑性，以最大限度地减少与生物组织的相互作用。现有的TPE材料缺乏这种润滑性，生物医学设备设计者被迫依赖于昂贵且复杂的亲水性表面处理或使用疏水性含氟聚合物衬里或树脂涂层来实现低表面摩擦和生物表面钝化。基于水凝胶的材料，由于其固有的润滑性和抑制生物活化的倾向，已被吹捧为此类装置中的可能参与者，该项目探索的水凝胶材料技术将是市场上首批能够满足大多数产品应用所需耐久性要求的技术之一。该奖项反映了NSF的法定使命，并通过使用基金会的知识产权进行评估，被认为值得支持。优点和更广泛的影响审查标准。